Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 7—July 2026
Research
Molecular Epidemiology of Skin-Dwelling Filariae and Risk Factors for Mansonella streptocerca Infection, Gabon
Table 3
Frequency of reported symptoms by infection status in study of molecular epidemiology of skin-dwelling filariae and risk factors for Mansonella streptocerca infection, Gabon*
| Symptoms | Total | No. (%) participants |
p value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ms+ 4 | Ms+ 3 | Ms+ 2 | Ms+ 1 | Ms– 4 | Ms– 3 | Ms– 2 | Ms– 1 | |||
| Urticaria | 976 | 57 (41) | 211 (25.2) | 17 (12.2) | 150 (17.9) | 15 (10.8) | 106 (12.7) | 50 (36) | 370 (44.2) | 0.003 |
| Fatigue or exhaustion | 971 | 40 (28.8) | 160 (19.2) | 20 (14.4) | 203 (24.4) | 17 (12.2) | 142 (17.1) | 62 (44.6) | 327 (39.3) | 0.727 |
| Cutaneous rash | 971 | 32 (22.9) | 117 (14.1) | 7 (5) | 113 (13.6) | 16 (11.4) | 97 (11.7) | 85 (60.7) | 504 (60.6) | 0.396 |
| Headaches | 978 | 48 (34.3) | 152 (18.1) | 14 (10) | 226 (27) | 26 (18.6) | 180 (21.5) | 52 (37.1) | 280 (33.4) | 0.266 |
| Stomach pain | 971 | 32 (23) | 85 (10.2) | 12 (8.6) | 116 (13.9) | 22 (15.8) | 171 (20.6) | 73 (52.5) | 460 (55.3) | 0.018 |
| Joint pain | 977 | 66 (47.5) | 325 (38.8) | 34 (24.5) | 152 (18.1) | 21 (15.1) | 115 (13.7) | 18 (12.9) | 246 (29.4) | <0.001 |
| Subcutaneous nodules | 947 | 23 (16.7) | 46 (5.7) | 48 (34.8) | 128 (15.8) | 4 (2.9) | 45 (5.6) | 63 (45.7) | 590 (72.9) | <0.001 |
*Ms+, PCR-positive for M. streptocerca (n = 143); Ms–, PCR-negative for M. streptocerca (n = 864). Numbers 1–4 indicate frequency of symptoms: 4, every day; 3, once a week; 2, once a month; 1, rarely/never. Bold p values indicate statistical significance (p<0.05).
Page created: May 14, 2026
Page updated: June 09, 2026
Page reviewed: June 09, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.